AAAAAA
Results:
1-8
|
Results: 8
Authors:
Swiercz, R
Keck, RW
Skrzypczak-Jankun, E
Selman, SH
Jankun, J
Citation: R. Swiercz et al., Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostatecancer xenografts in SCID mice, ONCOL REP, 8(3), 2001, pp. 463-470
Authors:
McDonough, MJ
Feldmeier, JJ
Parsai, I
Dobelbower, RR
Selman, SH
Citation: Mj. Mcdonough et al., Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer, INT J RAD O, 51(3), 2001, pp. 624-627
Authors:
Sindhwani, P
Hampton, JA
Baig, MM
Keck, R
Selman, SH
Citation: P. Sindhwani et al., Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice, J UROL, 166(4), 2001, pp. 1498-1501
Authors:
Selman, SH
Albrecht, D
Keck, RW
Brennan, P
Kondo, S
Citation: Sh. Selman et al., Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate, J UROL, 165(5), 2001, pp. 1795-1801
Authors:
Skrzypczak-Jankun, E
McCabe, NP
Selman, SH
Jankun, J
Citation: E. Skrzypczak-jankun et al., Curcumin inhibits lipoxygenase by binding to its central cavity: Theoretical and X-ray evidence, INT J MOL M, 6(5), 2000, pp. 521-526
Authors:
McCabe, NP
Angwafo, FF
Zaher, A
Selman, SH
Kouinche, A
Jankun, J
Citation: Np. Mccabe et al., Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients, ONCOL REP, 7(4), 2000, pp. 879-882
Authors:
Selman, SH
Citation: Sh. Selman, "Latent" carcinoma of the prostate: A medical misnomer?, UROLOGY, 56(4), 2000, pp. 708-711
Authors:
Swiercz, R
Skrzypczak-Jankun, E
Merrell, MM
Selman, SH
Jankun, J
Citation: R. Swiercz et al., Angiostatic activity of synthetic inhibitors of urokinase type plasminogenactivator, ONCOL REP, 6(3), 1999, pp. 523-526
Risultati:
1-8
|